Paediatric Consumer Health in Uruguay

In 2020, paediatric consumer health is expected to post a stronger current value growth rate than was seen in 2019. In fact, all subcategories, except for paediatric laxatives and digestive remedies, are expected to post stronger growth in 2020 in comparison to the previous year. Most notably, the growth of paediatric cough/cold remedies is fuelled by COVID-19 in 2020, a reversal from the slowdown in value growth seen in 2019. However, consumption is expected to normalise after the pandemic pass...

Euromonitor International's Paediatric Consumer Health in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Paediatric Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market's major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

TABLE OF CONTENTS

List OF CONTENTS AND TABLES

KEY DATA FINDINGS

2020 IMPACT

In 2020 COVID-19 fuels the growth of previously lacklustre paediatric cough/cold remedies, as well as paediatric vitamins and dietary supplements

Paediatric analgesics continue to grow, driven by the strong performance of paediatric acetaminophen which was initially recommend by the government for COVID-19

Bayer continues to lead paediatric vitamins and dietary supplements in 2020, experiencing an upturn from previously declining current value sales

RECOVERY AND OPPORTUNITIES

Over the forecast period slower but still solid growth is expected, with paediatric vitamins and dietary supplements set to lead the way

Demand for value-priced generic brands is set to increase over the forecast period

Healthier eating habits pose a hurdle to growth over the forecast period

CATEGORY DATA

• Table 1 Sales of Paediatric Consumer Health by Category: Value 2015-2020
• Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
• Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
• Table 4 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
• Table 5 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

• Table 6 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
• Table 7 Life Expectancy at Birth 2015-2020

MARKET DATA

• Table 8 Sales of Consumer Health by Category: Value 2015-2020
• Table 9 Sales of Consumer Health by Category: % Value Growth 2015-2020
• Table 10 NBO Company Shares of Consumer Health: % Value 2016-2020
• Table 11 LBN Brand Shares of Consumer Health: % Value 2017-2020
• Table 12 Distribution of Consumer Health by Format: % Value 2015-2020
• Table 13 Distribution of Consumer Health by Format and Category: % Value 2020
• Table 14 Forecast Sales of Consumer Health by Category: Value 2020-2025
• Table 15 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

• Summary 1 Research Sources